Bind-X develops biotechnology applications to improve the sustainability of industries by optimizing biotechnological processes.
Bind-X has raised $11.0M in total funding. The most recent round was Series B. The last funding was announced in August 2023.
Bind-X's investors include HTGF (High-Tech Gruenderfonds), HG Ventures, Saxovent, Greeneering Invest, Vantage Value.
Bind-X is headquartered in Planegg, Germany.
Bind-X develops biotechnology applications to improve the sustainability of industries by optimizing biotechnological processes.
Bind-X is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bind-X — Funding & Investors." VCBacked, August 1, 2023, https://www.vcbacked.co/company/bind-x. Accessed August 13, 2026.
VCBacked. (2023). Bind-X — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/bind-x
{{cite web |title=Bind-X — Funding & Investors |url=https://www.vcbacked.co/company/bind-x |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated